Lakewood-Amedex Biotherapeutics Inc.
corporate_fare Company Profile
Lakewood-Amedex Biotherapeutics Inc. (NASDAQ:LABT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 24 items for LABT at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Lakewood-Amedex Secures CRO for Nu-3 Phase 2 Trial, Advancing Lead Candidate
- Selling Stockholders Register Over 9.6M Shares for Resale, Posing Significant Dilution Risk Amidst Going Concern Warning
- Lead Candidate NU-3 Shows Strong Antimicrobial Resistance Data for Diabetic Foot Ulcers
- Lakewood-Amedex Appoints Biotech Veteran Dr. Joseph Tucker to Board, Bolstering Capital Markets Expertise
show_chartPrice Chart
Loading chart...
feed LABT - Filings & News (Page 2)
LABT
May 12, 2026, 8:02 AM EDT
Price at Filing:
$3.16
Real-time Price:
$0.235
Change:
Reverse Stock Split
Market Cap:
$2.192M
LABT
May 01, 2026, 4:05 PM EDT
Price at Filing:
$3.27
Real-time Price:
$0.235
Change:
Reverse Stock Split
Market Cap:
$2.192M
LABT
May 01, 2026, 9:33 AM EDT
Price at Filing:
$4.22
Real-time Price:
$0.235
Change:
Reverse Stock Split
Market Cap:
$2.192M
LABT
Apr 28, 2026, 4:15 PM EDT
Price at Filing:
$3.95
Real-time Price:
$0.235
Change:
Reverse Stock Split
Market Cap:
$2.192M